Study: NCT00845000

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SCH 420814 10 mg
Description: one 10-mg capsule, orally, at hour 0 of treatment period

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SCH 420814 10 mg
Description: one 10-mg capsule, orally, at hour 0 of treatment period

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SCH 420814 10 mg
Description: one 10-mg capsule, orally, at hour 0 of treatment period

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SCH 420814 10 mg
Description: one 10-mg capsule, orally, at hour 0 of treatment period

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SCH 420814 10 mg
Description: one 10-mg capsule, orally, at hour 0 of treatment period

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SCH 420814 10 mg
Description: one 10-mg capsule, orally, at hour 0 of treatment period

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SCH 420814 100 mg
Description: single oral dose of four SCH 420814 25-mg capsules at hour 0 of treatment period

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SCH 420814 100 mg
Description: single oral dose of four SCH 420814 25-mg capsules at hour 0 of treatment period

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SCH 420814 100 mg
Description: single oral dose of four SCH 420814 25-mg capsules at hour 0 of treatment period

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SCH 420814 100 mg
Description: single oral dose of four SCH 420814 25-mg capsules at hour 0 of treatment period

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SCH 420814 100 mg
Description: single oral dose of four SCH 420814 25-mg capsules at hour 0 of treatment period

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SCH 420814 100 mg
Description: single oral dose of four SCH 420814 25-mg capsules at hour 0 of treatment period

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo capsule, oral, at hour 0 of treatment period

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo capsule, oral, at hour 0 of treatment period

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo capsule, oral, at hour 0 of treatment period

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo capsule, oral, at hour 0 of treatment period

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo capsule, oral, at hour 0 of treatment period

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo capsule, oral, at hour 0 of treatment period

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Levodopa
Description: levodopa intravenous (IV) infusion (1 mg/kg body weight) was beginning 1 hour after study drug administration and continued for 2 hours

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Levodopa
Description: levodopa intravenous (IV) infusion (1 mg/kg body weight) was beginning 1 hour after study drug administration and continued for 2 hours

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Levodopa
Description: levodopa intravenous (IV) infusion (1 mg/kg body weight) was beginning 1 hour after study drug administration and continued for 2 hours

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Levodopa
Description: levodopa intravenous (IV) infusion (1 mg/kg body weight) was beginning 1 hour after study drug administration and continued for 2 hours

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Levodopa
Description: levodopa intravenous (IV) infusion (1 mg/kg body weight) was beginning 1 hour after study drug administration and continued for 2 hours